GlassScriptPhysician profile
Lori C Romberg
NPI 1821027574
$5,667.53
in general payments reported to CMS, 2019-2025
23 companies · $615 in 2025
The $615 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $39.84 · 2021: $95.84 · 2022: $3,654 · 2023: $474 · 2024: $417 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.45 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,593.75 | 2022 | |
| Hologic Sales and Service, LLC | $473.04 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Aptima |
| Astellas Pharma US INC | $330.29 | 2022-2025 | Veozah |
| Abbvie INC. | $245.22 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $140.34 | 2023-2025 | |
| Sage Therapeutics, LLC | $93.11 | 2023-2025 | Zurzuvae |
| Minerva Surgical, INC | $92.78 | 2021-2024 | |
| Smith+Nephew, INC. | $86.24 | 2019-2024 | Pico 14 |
| Coopersurgical, INC. | $79.32 | 2019-2025 | Ally II Ups |
| Bayer Healthcare Pharmaceuticals INC. | $72.87 | 2019-2025 | |
| Organon LLC | $65.31 | 2022-2025 | Nexplanon |
| Pfizer INC. | $61.27 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $59.28 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $52.67 | 2023-2024 | Slynd |
| Millicent US INC | $49.51 | 2020-2025 | Femring, Intrarosa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $38.95 | 2025 | |
| Merck Sharp & Dohme LLC | $29.89 | 2019 | |
| Exact Sciences Corporation | $25.09 | 2025 | The Cologuard Plus Collection Kit |
| Meditrina | $16.75 | 2025 | |
| Duchesnay USA Incorporated | $16.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.94 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.01 | 2025 | Qelbree |
| Vertical Pharmaceuticals, LLC | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Romberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.